1. Resurgent Malaria at the Millennium

   • J. Kevin Baird

   Current Opinion 27 November 2012 Pages: 719 - 743

   

2. Role of Tumour Necrosis Factor-α in the Progression of Heart Failure

   • Guillermo Torre-Amione
   • Mary T. Vooletich
   • John A. Farmer

   Leading Article 27 November 2012 Pages: 745 - 751

   

3. Tyrosine Kinase Inhibitors Targeted to the Epidermal Growth Factor Receptor Subfamily

   • Sarah B. Noonberg
   • Christopher C. Benz

   Review Article 27 November 2012 Pages: 753 - 767

   

4. Systemic Enzyme Therapy in Oncology

   • Jörg Leipner
   • Reinhard Saller

   Review Article 27 November 2012 Pages: 769 - 780

   

5. A Risk-Benefit Assessment of Pharmacological and Nonpharmacological Treatments for Nausea and Vomiting of Pregnancy

   • Paolo Mazzotta
   • Laura A. Magee

   Review Article 27 November 2012 Pages: 781 - 800

   

6. Concurrent Gonococcal and Chlamydial Infection

   • Angela J. Robinson
   • Geoffrey L. Ridgway

   Disease Management 27 November 2012 Pages: 801 - 813

   

7. Linezolid

   • Delyth Clemett
   • Anthony Markham

   Adis New Drug Profile 27 November 2012 Pages: 815 - 827

   

8. Linezolid

   • Gary A. Noskin

   Adis New Drug Profile 27 November 2012 Pages: 828 - 828

9. Linezolid

   • Richard Wise

   Adis New Drug Profiles 27 November 2012 Pages: 828 - 828

10. Racecadotril

    • Anna J. Matheson
    • Stuart Noble

    Adis New Drug Profile 27 November 2012 Pages: 829 - 835

    

11. Racecadotril

    • Lulu C. Bravo

    Adis New Drug Profile 27 November 2012 Pages: 836 - 836

12. Racecadotril

    • Herbert L. DuPont

    Adis New Drug Profile 27 November 2012 Pages: 836 - 837

13. Valaciclovir

    • Douglas Ormrod
    • Lesley J. Scott
    • Caroline M. Perry

    Adis Drug Evaluation 27 November 2012 Pages: 839 - 863

    

14. Zolpidem

    • Kristin J. Holm
    • Karen L. Goa

    Adis Drug Evaluation 27 November 2012 Pages: 865 - 889

    

15. Montelukast

    • Blair Jarvis
    • Anthony Markham

    Adis Drug Evaluation 27 November 2012 Pages: 891 - 928

    

16. Prolonged-Release Mesalazine

    • Delyth Clemett
    • Anthony Markham

    Adis Drug Evaluation 27 November 2012 Pages: 929 - 956

    

17. Celecoxib

    • Delyth Clemett
    • Karen L. Goa

    Adis Drug Evaluation 27 November 2013 Pages: 957 - 980

    

18. Ebastine

    • Miriam Hurst
    • Caroline M. Spencer

    Adis Drug Evaluation 27 November 2012 Pages: 981 - 1006

    

19. Bupropion

    • Kristin J. Holm
    • Caroline M. Spencer

    Adis Drug Evaluation 27 November 2012 Pages: 1007 - 1024